A. Agrawal

发表

The ‘other half’ of breast cancer: A review of male breast cancer

K. Cheung, M. Ying, A. Agrawal, 2005 .

Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? A prospective study.

A. Evans, K. Cheung, J. James, 2008, Breast.

Pilot randomised study of early intervention based on tumour markers in the follow-up of patients with primary breast cancer.

K. Cheung, E. Gutteridge, C. Marenah, 2014, Breast.

"Resurrection of clinical efficacy" after resistance to endocrine therapy in metastatic breast cancer

J. Robertson, A. Agrawal, K. Cheung, 2006, World journal of surgical oncology.

Bone turnover markers in postmenopausal breast cancer treated with fulvestrant--a pilot study.

R. Eastell, K. Cheung, J. Robertson, 2009, Breast.

Fulvestrant in Advanced Male Breast Cancer

J. Robertson, K. Cheung, A. Agrawal, 2006, Breast Cancer Research and Treatment.

Biological profile of oestrogen receptor positive primary breast cancers in the elderly and response to primary endocrine therapy.

I. Ellis, A. Green, E. Paish, 2009, Critical reviews in oncology/hematology.

Suppression of ovarian function in combination with an aromatase inhibitor as treatment for advanced breast cancer in pre-menopausal women.

M. Dowsett, K. Cheung, J. Robertson, 2010, European journal of cancer.

Clinical relevance of "withdrawal therapy" as a form of hormonal manipulation for breast cancer

J. Robertson, A. Agrawal, K. Cheung, 2011, World journal of surgical oncology.

Oncoplastic breast surgery in elderly primary breast cancer: time to serve more surgically?

E. Garreffa, A. Agrawal, 2022, European Journal of Plastic Surgery.

CONCEPTS OF SEROMA FORMATION AND PREVENTION IN BREAST CANCER SURGERY

K. Cheung, A. Ayantunde, A. Agrawal, 2006, ANZ journal of surgery.

Breast cancer management pathways during the COVID-19 pandemic: outcomes from the UK ‘Alert Level 4’ phase of the B-MaP-C study

Mohammad Amir Sharif, Z. Rayter, R. Bonomi, 2020, British Journal of Cancer.

Serum epidermal growth factor receptor and HER2 expression in primary and metastatic breast cancer patients

I. Ellis, J. Robertson, C. Chapman, 2007, Breast Cancer Research.

Efficacy and tolerability of high dose " ethinylestradiol " in post-menopausal advanced breast cancer patients heavily pretreated with endocrine agents

J. Robertson, A. Agrawal, K. Cheung, 2015 .

Efficacy and tolerability of high dose "ethinylestradiol" in post-menopausal advanced breast cancer patients heavily pre-treated with endocrine agents

J. Robertson, A. Agrawal, K. Cheung, 2006, World journal of surgical oncology.

Overview of tyrosine kinase inhibitors in clinical breast cancer.

J. Robertson, R. Nicholson, J. Gee, 2005, Endocrine-related cancer.

Biological effects of fulvestrant on estrogen receptor positive human breast cancer: short, medium and long‐term effects based on sequential biopsies

I. Ellis, J. Robertson, R. Nicholson, 2015, International journal of cancer.

The effects of gefitinib in tamoxifen‐resistant and hormone‐insensitive breast cancer: A phase II study

R. Nicholson, K. Cheung, E. Gutteridge, 2010, International journal of cancer.

Neoadjuvant chemotherapy in locally advanced primary breast cancers: the Nottingham experience.

I. Ellis, K. Cheung, S. Chan, 2007, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Primary endocrine therapy in locally advanced breast cancers—the Nottingham experience

L. Jackson, K. Cheung, S. Buhari, 2007, Breast Cancer Research and Treatment.

Bone turnover markers in postmenopausal breast cancer patients treated with fulvestrant

R. Eastell, K. Cheung, J. Robertson, 2006 .

Prevalence and Clinical Outcome of FMS-Like Tyrosine Kinase Mutations Among Patients With Core Binding Factor-Acute Myeloid Leukemia: Systematic Review and Meta-Analysis.

Shyam Srinivasan, Shathish Kumar, A. Agrawal, 2021, Clinical lymphoma, myeloma & leukemia.

Goserelin plus anastrozole (G+A) as first-line systemic therapy for premenopausal estrogen receptor positive (ER+) advanced breast cancer (ABC)— clinical and endocrine data

K. Cheung, J. Robertson, L. Winterbottom, 2008 .

Male breast cancer: a review of clinical management

J. Robertson, R. Rampaul, A. Ayantunde, 2007, Breast Cancer Research and Treatment.

The Use of Latissimus Dorsi Miniflap for Reconstruction Following Breast-conserving Surgery: Experience of a Small Breast Unit in a District Hospital

A. Agrawal, A. Agrawal, K. Kolar, 2006, World Journal of Surgery.

Suppression of ovarian function in combination with an aromatase inhibitor as treatment for advanced breast cancer in pre-menopausal women.

J. Robertson, E. Folkerd, L. Winterbottom, 2010, European journal of cancer.

The effects of gefitinib in tamoxifen‐resistant and hormone‐insensitive breast cancer: A phase II study

R. Nicholson, K. Cheung, E. Gutteridge, 2010, International journal of cancer.

Efficacy and tolerability of high dose "ethinylestradiol" in post-menopausal advanced breast cancer patients heavily pre-treated with endocrine agents

J. Robertson, A. Agrawal, K. Cheung, 2006, World journal of surgical oncology.

"Resurrection of clinical efficacy" after resistance to endocrine therapy in metastatic breast cancer

J. Robertson, A. Agrawal, K. Cheung, 2006, World journal of surgical oncology.